ATryn FDA Approval History
FDA Approved: Yes (First approved February 6, 2009)
Brand name: ATryn
Generic name: Antithrombin (Recombinant)
Company: GTC Biotherapeutics, Inc.
Treatment for: Antithrombin III Deficiency
ATryn (Antithrombin (Recombinant)) is a recombinant form of human antithrombin for the prevention of peri-operative and peri-partum thromboembolic events in hereditary antithrombin deficient patients.
Development Timeline for ATryn
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.